Results 81 to 90 of about 5,177 (98)

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy

Journal of Hepatology, 2022
Jia Fan, Bo Hu, Lei Guo
exaly  

Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors

Progress in Biophysics and Molecular Biology, 2021
Chris A Brosey, Andrew Arvai, Panagiotis Katsonis   +2 more
exaly  

The interplay of TARG1 and PARG protects against genomic instability

Cell Reports, 2023
Ivan Ahel, Anne R Wondisford
exaly  

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality

Cancer Cell, 2018
Marieke van de Ven, Haico van Attikum, Marcel A.T.M. van Vugt   +2 more
exaly  

Relationship of PARG with PARP, VEGF and b-FGF in colorectal carcinoma

Chinese Journal of Cancer Research: Official Journal of China Anti-Cancer Association, Beijing Institute for Cancer Research, 2009
Ya-Lan Wang
exaly  

Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell death

British Journal of Pharmacology, 2008
Laura Formentini, Stefano Menichetti, Lisa Giovannelli   +2 more
exaly  

PARG Promotes Esophagus Cancer Cell Metastasis by Activation of the Wnt/β-Catenin Pathway

Biochemical Genetics, 2023
exaly  

Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat

Brain Research, 2003
Jia-He Li
exaly  

PARG dysfunction enhances DNA double strand break formation in S-phase after alkylation DNA damage and augments different cell death pathways

Cell Death and Disease, 2013
M Masutani
exaly  

PARG activity mediates intestinal injury induced by splanchnic artery occlusion and reperfusion.

FASEB Journal, 2005
Salvatore Cuzzocrea, Rosanna Di Paola, Tiziana GENOVESE   +2 more
exaly